ARTICLE | Company News
AstraZeneca dental, genitourinary news
December 6, 2010 8:00 AM UTC
AstraZeneca began a formal review of strategic options for its dental and urological products division, Astra Tech AB. JP Morgan Chase is advising the pharma. The division had 2009 sales of $506 milli...